title: Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis.
authors.affiliation: Department of Dermatology, Toyokawa City Hospital, Toyokawa, Japan.|Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
authors.forename: Koji
authors.initials: K
authors.lastname: Kamiya
authors.affiliation: Department of Dermatology, Kawasaki Hospital, Kawasaki Medical School, Okayama, Japan.
authors.forename: Yumi
authors.initials: Y
authors.lastname: Aoyama
authors.affiliation: Department of Dermatology, Toyokawa City Hospital, Toyokawa, Japan.
authors.forename: Eiichi
authors.initials: E
authors.lastname: Nishio
authors.affiliation: Department of Dermatology, Toyokawa City Hospital, Toyokawa, Japan.
authors.forename: Ai
authors.initials: A
authors.lastname: Horio
authors.affiliation: Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Tokura
mesh_terms: D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001324:Autoantigens / Q000276:immunology; D054414:Chemokine CCL17 / Q000097:blood; D003176:Complement C3 / Q000378:metabolism; D003876:Dermatitis, Atopic / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000378:metabolism; D007074:Immunoglobulin G / Q000097:blood / Q000378:metabolism; D008875:Middle Aged; D008911:Minocycline / Q000008:administration & dosage / Q000627:therapeutic use; D024041:Non-Fibrillar Collagens / Q000276:immunology; D010391:Pemphigoid, Bullous / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D012720:Severity of Illness Index; D012867:Skin / Q000473:pathology; D000097805:Collagen Type XVII
chemical_list: D000900:Anti-Bacterial Agents; D001324:Autoantigens; D054414:Chemokine CCL17; D003176:Complement C3; D005938:Glucocorticoids; D007073:Immunoglobulin E; D007074:Immunoglobulin G; D008911:Minocycline; D024041:Non-Fibrillar Collagens; D011239:Prednisolone; D000097805:Collagen Type XVII; C106230:CCL17 protein, human